1. Stewart J, Oware K, Donnell D, Violette LR, Odoyo J, Soge OO, Scoville CW, Omollo V, Mogaka FO, Sesay FA, McClelland RS. Doxycycline prophylaxis to prevent sexually transmitted infections in women. New England Journal of Medicine. 2023 Dec 21;389(25):2331-40.
2. Luetkemeyer AF, Donnell D, Dombrowski JC, et al. Postexposure doxycycline to prevent bacterial sexually transmitted infections. New England Journal of Medicine. 2023 Apr 6;388(14):1296-306.
3. Bachmann LH. CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024. MMWR. Recommendations and Reports. 2024;73.
4. Werner RN, Schmidt AJ, Potthoff A, Spornraft‐Ragaller P, Brockmeyer NH, German STI Society (DSTIG). Position statement of the German STI Society on the prophylactic use of doxycycline to prevent STIs (Doxy‐PEP, Doxy‐PrEP). JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2024 Mar;22(3):466-78.
5. Cornelisse VJ, Riley B, Medland NA. Australian consensus statement on doxycycline post‐exposure prophylaxis (doxy‐PEP) for the prevention of syphilis, chlamydia and gonorrhoea among gay, bisexual and other men who have sex with men. Medical Journal of Australia. 2024 Apr 15;220(7):381-6.
6. Grant JS, Stafylis C, Celum C, Grennan T, Haire B, Kaldor J, Luetkemeyer AF, Saunders JM, Molina JM, Klausner JD. Doxycycline prophylaxis for bacterial sexually transmitted infections. Clinical Infectious Diseases. 2020 Mar 3;70(6):1247-53.
7. Molina JM, Charreau I, Chidiac C, et al; ANRS IPERGAY Study Group. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis. 2018 Mar;18(3):308-317. doi: 10.1016/S1473-3099(17)30725-9.